211 related articles for article (PubMed ID: 17522219)
1. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells.
Twu KY; Kuo RL; Marklund J; Krug RM
J Virol; 2007 Aug; 81(15):8112-21. PubMed ID: 17522219
[TBL] [Abstract][Full Text] [Related]
2. Influenza a virus polymerase is an integral component of the CPSF30-NS1A protein complex in infected cells.
Kuo RL; Krug RM
J Virol; 2009 Feb; 83(4):1611-6. PubMed ID: 19052083
[TBL] [Abstract][Full Text] [Related]
3. The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.
Twu KY; Noah DL; Rao P; Kuo RL; Krug RM
J Virol; 2006 Apr; 80(8):3957-65. PubMed ID: 16571812
[TBL] [Abstract][Full Text] [Related]
4. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.
Noah DL; Twu KY; Krug RM
Virology; 2003 Mar; 307(2):386-95. PubMed ID: 12667806
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for suppression of a host antiviral response by influenza A virus.
Das K; Ma LC; Xiao R; Radvansky B; Aramini J; Zhao L; Marklund J; Kuo RL; Twu KY; Arnold E; Krug RM; Montelione GT
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13093-8. PubMed ID: 18725644
[TBL] [Abstract][Full Text] [Related]
6. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins.
Spesock A; Malur M; Hossain MJ; Chen LM; Njaa BL; Davis CT; Lipatov AS; York IA; Krug RM; Donis RO
J Virol; 2011 Jul; 85(14):7048-58. PubMed ID: 21593152
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening of potential inhibitors from TCM for the CPSF30 binding site on the NS1A protein of influenza A virus.
Ai H; Zhang L; Chang AK; Wei H; Che Y; Liu H
J Mol Model; 2014 Mar; 20(3):2142. PubMed ID: 24562912
[TBL] [Abstract][Full Text] [Related]
8. Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30.
Dankar SK; Miranda E; Forbes NE; Pelchat M; Tavassoli A; Selman M; Ping J; Jia J; Brown EG
Virol J; 2013 Jul; 10():243. PubMed ID: 23886034
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding and effector domains of the viral NS1 protein are conserved to different extents among influenza A and B viruses.
Wang W; Krug RM
Virology; 1996 Sep; 223(1):41-50. PubMed ID: 8806538
[TBL] [Abstract][Full Text] [Related]
10. [Development of a yeast two-hybrid screen for selection of A/H1N1 influenza NS1 non-structural protein and human CPSF30 protein interaction inhibitors].
Kong JQ; Shen JH; Huang Y; Ruan RY; Xiang B; Zheng XD; Cheng KD; Wang W
Yao Xue Xue Bao; 2010 Mar; 45(3):388-94. PubMed ID: 21351518
[TBL] [Abstract][Full Text] [Related]
11. Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery.
Chen Z; Li Y; Krug RM
EMBO J; 1999 Apr; 18(8):2273-83. PubMed ID: 10205180
[TBL] [Abstract][Full Text] [Related]
12. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode.
Chien CY; Xu Y; Xiao R; Aramini JM; Sahasrabudhe PV; Krug RM; Montelione GT
Biochemistry; 2004 Feb; 43(7):1950-62. PubMed ID: 14967035
[TBL] [Abstract][Full Text] [Related]
13. Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA.
Li S; Min JY; Krug RM; Sen GC
Virology; 2006 May; 349(1):13-21. PubMed ID: 16466763
[TBL] [Abstract][Full Text] [Related]
14. A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro.
Lee J; Park JH; Min JY
Arch Virol; 2017 Jan; 162(1):13-21. PubMed ID: 27400993
[TBL] [Abstract][Full Text] [Related]
15. Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation.
Wang BX; Brown EG; Fish EN
Virology; 2017 Aug; 508():170-179. PubMed ID: 28554059
[TBL] [Abstract][Full Text] [Related]
16. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes.
Melén K; Kinnunen L; Fagerlund R; Ikonen N; Twu KY; Krug RM; Julkunen I
J Virol; 2007 Jun; 81(11):5995-6006. PubMed ID: 17376915
[TBL] [Abstract][Full Text] [Related]
17. Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions.
Aramini JM; Ma LC; Zhou L; Schauder CM; Hamilton K; Amer BR; Mack TR; Lee HW; Ciccosanti CT; Zhao L; Xiao R; Krug RM; Montelione GT
J Biol Chem; 2011 Jul; 286(29):26050-60. PubMed ID: 21622573
[TBL] [Abstract][Full Text] [Related]
18. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway.
Min JY; Krug RM
Proc Natl Acad Sci U S A; 2006 May; 103(18):7100-5. PubMed ID: 16627618
[TBL] [Abstract][Full Text] [Related]
19. Three amino acid substitutions in the NS1 protein change the virus replication of H5N1 influenza virus in human cells.
Li J; Zhang K; Chen Q; Zhang X; Sun Y; Bi Y; Zhang S; Gu J; Li J; Liu D; Liu W; Zhou J
Virology; 2018 Jun; 519():64-73. PubMed ID: 29677653
[TBL] [Abstract][Full Text] [Related]
20. Avian-derived NS gene segments alter pathogenicity of the A/Puerto Rico/8/34 virus.
Park SJ; Lee EH; Choi EH; Pascua PN; Kwon HI; Kim EH; Lim GJ; Decano A; Kim SM; Choi YK
Virus Res; 2014 Jan; 179():64-72. PubMed ID: 24269912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
